Candida auris infections in an intensive care unit: Antifungal resistance, mortality rates and infection control interventions
Acta Microbiologica et Immunologica Hungarica · 2025
DOI: 10.1556/030.2025.02615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2025. Verfasst von Semiha Solak Grassie und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Yıldırım Beyazıt University Yenimahalle Training and Research Hospital, Infectious Diseases Clinic, Ankara, Turkiye. Hauptthemen laut MEDLINE: Antifungal Agents, Candida auris, Candidiasis, Drug Resistance, Fungal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Intensivpflege, Nosokomiale Infektionen
Abstract (Originalsprache)
Candida auris spreads rapidly and causes outbreaks worldwide. Strict infection control is critical to control its spread; however, it is challenging and requires a special approach. This study aims to investigate the colonization and infection of C. auris in intensive care units (ICUs), analyses its susceptibility, and mortality rates, and contributes to an effective infection control. An infection control study was planned, and a C. auris infection control bundle and checklist were developed. During the study's pre-intervention, intervention, and post-intervention periods, C. auris candidemia cases and colonized patients were identified. Until the infection control intervention, all the candidemia cases, antifungal resistance, and mortality were investigated retrospectively. Clinical isolates were identified by phenotypic and genotypic characterization using MALDI-TOF MS Biotyper (Bruker Daltonics, Bremen, Germany) and sequencing. During the pre-intervention, intervention, and post-intervention periods, 26 C. auris cases were identified. Pan-resistant C. auris isolates were 3.84%, and the multidrug resistance was 65.38%. With the infection control intervention, the number of colonized patients decreased (pre-intervention 9.61‰, intervention 6.19‰, post-intervention 5.20‰). Candidemia incidence decreased from 4.09 to 2.3‰. No new cases of candidemia were observed at the end of the study. The risk of new cases is elevated in the rooms where multiple C. auris cases have been previously isolated. Mortality rate was high; namely, 76.92% of patients died, and 19.23% of strains were resistant to anidulofungin, one of the most commonly used antifungals. Despite the short implementation period, the infection control bundle and checklist have been demonstrated to be effective in controlling C. auris spread in the ICU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Yıldırım Beyazıt University Yenimahalle Training and Research Hospital, Infectious Diseases Clinic, Ankara, Turkiye.
- 2Public Health Institute of Turkiye, National Mycology Reference Laboratory, Ankara, Turkiye.
- 3Yıldırım Beyazıt University Yenimahalle Training and Research Hospital, Microbiology Laboratory, Ankara, Turkiye.
ORCID-Profile: Semiha Solak Grassie
Zitieren
APA
Solak Grassie, S., Karabıçak, N., & Ünalan Altıntop, T. (2025). Candida auris infections in an intensive care unit: Antifungal resistance, mortality rates and infection control interventions. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2025.02615
Vancouver
Solak Grassie S, Karabıçak N, Ünalan Altıntop T. Candida auris infections in an intensive care unit: Antifungal resistance, mortality rates and infection control interventions. Acta Microbiologica et Immunologica Hungarica. 2025. doi:10.1556/030.2025.02615
BibTeX
@article{SolakGrassie2025,
author = {Solak Grassie, Semiha and Karabıçak, Nilgün and Ünalan Altıntop, Tuğçe},
title = {Candida auris infections in an intensive care unit: Antifungal resistance, mortality rates and infection control interventions},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2025},
doi = {10.1556/030.2025.02615}
}
EUVIMED